First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors
EMB-02(一种靶向PD-1和LAG-3的双特异性抗体)在晚期实体瘤患者中的首次人体I期研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-02990-x
Day, Daphne; Ganju, Vinod; Chung, Ki; Si, Lu; Mao, Lili; Aghmesheh, Morteza; Hoyer, Robert; Brewin, Kim; Zeng, Shuqi; Zhang, Mingfei; Lu, Qiaoyang; Jiang, Chengjun; Ren, Fang; Zhu, Yonghong; Guo, Jun